
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2026-09-17CAG3Power of Attorney for Amy C. Held
This filing documents a Power of Attorney granted by Amy C. Held, EVP & Chief Admin. Officer of Conagra Brands, Inc., to Carey Bartell, McLaurin Files, and Henry Turner. The attorneys-in-fact are authorized to execute and submit necessary SEC filings, including Forms 3, 4, 5, and 144, on behalf of Ms. Held. This author...
Mid CapPackaged Foods
2026-09-17JACK3Initial Statement of Beneficial Ownership of Securities
This filing is an Initial Statement of Beneficial Ownership of Securities filed by Montgomery Taylor K, who is the EVP, President of JACK IN THE BOX INC. The filing indicates that there are no securities owned directly by the reporting owner as of the period of report, September 14, 2026. The signature date was Septemb...
Micro CapRestaurants
2026-09-17YYAI3Initial Statement of Beneficial Ownership of Securities
This filing is an Initial Statement of Beneficial Ownership of Securities (Form 3) for Ji Guibao, Chief Financial Officer and Director of AIRWA INC. The reporting owner, Ji Guibao, reported that they own 0 securities. The filing pertains to the period of report of November 21, 2024, and was signed on September 17, 2026...
Nano CapLeisure
2026-09-17KPRX3Limited Power of Attorney for Keith J. Lane
This filing details a Limited Power of Attorney granted by Keith J. Lane, EVP, Clinical and Regulatory at Kiora Pharmaceuticals, Inc., to Brian M. Strem and Melissa Tosca. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5, including amendments, with the SEC and other relevant bodies regarding K...
Nano CapBiotechnology
2026-09-17KIORA PHARMACEUTICALS INC3Limited Power of Attorney for Keith J. LaneDuplicate
This filing details a Limited Power of Attorney granted by Keith J. Lane, EVP, Clinical and Regulatory at Kiora Pharmaceuticals, Inc., to Brian M. Strem and Melissa Tosca. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5, including amendments, with the SEC and other relevant bodies regarding K...
Nano CapBiotechnology
2026-09-17MYGN3Form 3 Filing for Vishal Sikri - EVP, Commercial at Myriad Genetics Inc.
This filing is an initial report (Form 3) for Vishal Sikri, who holds the position of EVP, Commercial at Myriad Genetics Inc. (MYGN). The report indicates that Mr. Sikri directly owns 93,493 shares of the company's common stock following a transaction. The filing also includes Exhibit 24, a Power of Attorney document r...
Small CapDiagnostics & Research
Sponsored
Sponsored
Sponsored